Is It Time to Reconsider the Lipopolysaccharide Paradigm in Acute Graft-Versus-Host Disease?

Etienne Daguindau; Thomas Gautier; Cécile Chagué; Jean-Paul Pais de Barros; Valérie Deckert; Laurent Lagrost; Philippe Saas

doi:10.3389/fimmu.2017.00952

Is It Time to Reconsider the Lipopolysaccharide Paradigm in Acute Graft-Versus-Host Disease?

Front Immunol. 2017 Aug 9:8:952. doi: 10.3389/fimmu.2017.00952. eCollection 2017.

Authors

Etienne Daguindau^{1

2

3}, Thomas Gautier^{4

5}, Cécile Chagué^{1

2}, Jean-Paul Pais de Barros^{4

5}, Valérie Deckert^{4

5}, Laurent Lagrost^{4

5

6}, Philippe Saas^{1

2

3}

Affiliations

¹ Université Bourgogne Franche-Comté, EFS Bourgogne Franche-Comté, INSERM, UMR1098, Besançon, France.
² Department of Hematology, University Hospital of Besançon, Besançon, France.
³ LipSTIC LabEx, FHU INCREASE, Besançon, France.
⁴ INSERM, Université Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
⁵ LipSTIC LabEx, Dijon, France.
⁶ University Hospital of Dijon, Dijon, France.

No abstract available

Keywords: Escherichia coli; PLTP; TLR4; endotoxin; graft-versus-host disease; lipopolysaccharide; lipoproteins; microbiota.